ReviewPharmacoEconomics2026

Balancing Access and Value in Multi-Indication Medicines: Implications of PD-(L)1 Broad Listings in Australia.

Isaiah Luc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.